Serial procalcitonin levels to detect bacteremia in febrile neutropenia

Clinical Pediatrics

Volumn 51, Issue 12, 2012, Pages 1175-1183

  Reitman, Aaron J ^a,b   Pisk, Rhonda M ^b   Gates, John V ^a,b   Ozeran, J Daniel ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

Author keywords

febrile; neutropenia; oncology; pediatric; procalcitonin

Indexed keywords

PROCALCITONIN;

ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM CULTURE; BLOOD CULTURE; CANCER PATIENT; FEBRILE NEUTROPENIA; HOSPITAL ADMISSION; HUMAN; PREDICTIVE VALUE; PROSPECTIVE STUDY;

ADOLESCENT; AREA UNDER CURVE; BACTEREMIA; CALCITONIN; CALIFORNIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FEVER; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84870505820     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922812460913     Document Type: Article

References (48)

1. Pizzo PA. Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. J Pediatr. 1981 ; 98: 341-354 (Pubitemid 11106233)
2. Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R. Emergence of carbapenem resistant gram negative and vancomycin resistant gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis. 2008 ; 8: 80
3. Elting LS, Lu C, Escalante CP, et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol. 2008 ; 26: 606-611 (Pubitemid 351264355)
4. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults. Br J Haematol. 1997 ; 99: 580-588 (Pubitemid 27519860)
5. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002 ; 34: 730-751 (Pubitemid 34194843)
6. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol. 1992 ; 10: 316-322
7. Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002 ; 24: 38-42 (Pubitemid 34094328)
8. Ammann RA, Hirt A, Luthy AR, Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003 ; 41: 436-443 (Pubitemid 37229435)
9. Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatric Infect Dis. 2004 ; 23: 61-67 (Pubitemid 38176764)
10. Hakim H, Flynn PM, Srivastava DK, et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatric Infect Dis. 2010 ; 29: 53-59
11. Holdsworth M, Hanrahan J, Albanese B, Frost J. Outpatient management of febrile neutropenia in children with cancer. Paediatr Drugs. 2003 ; 5: 443-455 (Pubitemid 36976115)
12. Jones GR, Konsler GK, Dunaway RP, Pusek SN. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol. 1996 ; 13: 217-229 (Pubitemid 26146273)
13. Kocak U, Rolston KV, Mullen CA. Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia. Support Care Cancer. 2002 ; 10: 58-64 (Pubitemid 36055886)
14. Rondinelli PI, Ribeiro Kde C, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol. 2006 ; 28: 665-670 (Pubitemid 44540164)
15. Karthaus M, Egerer G, Jurgens H. Outpatient treatment of cancer patients with fever and neutropenia. Antibiot Chemother. 2000 ; 50: 47-58
16. Klaassen RJ, Goodman TR, Pham B, Doyle JJ. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000 ; 18: 1012-1019 (Pubitemid 30123777)
17. Meckler G, Lindemulder S. Fever and neutropenia in pediatric patients with cancer. Emerg Med Clin North Am. 2009 ; 27: 525-544
18. Santolaya ME, Alvarez AM, Aviles CL, et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis. 2002 ; 35: 678-683 (Pubitemid 35024727)
19. Santolaya ME, Alvarez AM, Aviles CL, et al. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial. Pediatric Infect Dis. 2008 ; 27: 538-543
20. Macher E, Dubos F, Garnier N, et al. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatr Blood Cancer. 2010 ; 55: 662-667
21. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993 ; 328: 1323-1332
22. Kara A, Kanra G, Cengiz AB, Api M, Gür D. Pediatric blood culture: time to positivity. Turk J Pediatr. 2004 ; 46: 251-255 (Pubitemid 39276583)
23. Towns ML, Jarvis WR, Hsueh PR. Guidelines on blood cultures. J Microbiol Immunol Infect. 2010 ; 43: 347-349
24. Isaacman DJ, Karasic RB, Reynolds EA, Kost SI. Effect of number of blood cultures and volume of blood on detection of bacteremia in children. J Pediatr. 1996 ; 128: 190-195 (Pubitemid 26065941)
25. Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996 ; 23: 40-46 (Pubitemid 26323793)
26. Avabratha KS, Rau AT, Venkataravanamma P, Rau A. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies. Indian Pediatr. 2009 ; 46: 797-799
27. Martinez-Albarran M, Perez-Molina Jde J, Gallegos-Castorena S, et al. Procalcitonin and c-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer. Pediatr Hematol Oncol. 2009 ; 26: 414-425
28. Miedema KG, de Bont ES, Elferink RF, et al. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer. 2011 ; 19: 1593-1600
29. Secmeer G, Devrim I, Kara A, et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol. 2007 ; 29: 107-111 (Pubitemid 46213857)
30. Spasova MI, Terzieva DD, Tzvetkova TZ, et al. Interleukin-6, interleukin-8, interleukin-10, and c-reactive protein in febrile neutropenia in children with malignant diseases. Folia Med (Plovdiv). 2005 ; 47: 46-52
31. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998 ; 24: 888-889
32. Muller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001 ; 86: 396-404 (Pubitemid 32109825)
33. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011 ; 27: 253-263
34. Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection. 2008 ; 36: 396-407
35. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007 ; 26: 672-677 (Pubitemid 47424634)
36. de Bont ES, Vellenga E, Swaanenburg J, Kamps W. Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?. Infection. 2000 ; 28: 398-400
37. Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U. Procalcitonin-A sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med. 2000 ; 26: S202 - S211
38. Hatzistilianou M. Diagnostic and prognostic role of procalcitonin in infections. ScientificWorldJournal. 2010 ; 10: 1941-1946
39. Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis. 2006 ; 25: 413-415 (Pubitemid 43885690)
40. Barnes C, Ignjatovic V, Newall F, et al. Change in serum procalcitonin (deltapct) predicts the clinical outcome of children admitted with febrile neutropenia. Br J Haematol. 2002 ; 118: 1197-1198 (Pubitemid 35025997)
41. BRAHMS PCT. Welcome to PCT. Thermoscientific Web site. http://www.procalcitonin.com. Accessed February 15, 2012.
42. Clinical Modification. 9 -CM: International Classification of Diseases, 9th rev; Clinical Modification. 6th ed.2006. Vols. 1-3. Los Angeles, CA: Practice Management Information Corporation; 2006. Los Angeles, CA: Practice Management Information Corporation ; 2006 2006 :
43. Gonsalves WI, Cornish N, Moore M, Chen A, Varman M. Effects of volume and site of blood draw on blood culture results. J Clin Microbiol. 2009 ; 47: 3482-3485
44. Li J, Plorde JJ, Carlson LG. Effects of volume and periodicity on blood cultures. J Clin Microbiol. 1994 ; 32: 2829-2831 (Pubitemid 24319127)
45. Svaldi M, Hirber J, Lanthaler AI, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol. 2001 ; 115: 53-57 (Pubitemid 32995092)
46. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis. 2001 ; 32: 1718-1725 (Pubitemid 32532002)
47. Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001 ; 92: 909-913 (Pubitemid 32783080)
48. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol. 1996 ; 14: 919-924 (Pubitemid 26085537)